Last update 14 Jun 2025

177Lu-JH04

Overview

Basic Info

Drug Type
Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals
Synonyms-
Target
FAP
Action
antagonists
Mechanism
FAP antagonists(Fibroblast activation protein alpha antagonists)
Therapeutic Areas
NeoplasmsCongenital DisordersDigestive System Disorders+ [1]
Active Indication
Adenomatous Polyposis ColiAdvanced cancerNeoplasm Metastasis+ [1]
Inactive Indication-
Originator Organization
First Affiliated Hospital Of Fujian Medical University
Active Organization
First Affiliated Hospital Of Fujian Medical UniversityBivision Biomedical Technology (Nanjing) Co., Ltd.Bivision Biomedical Technology (Nanjing) Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with 177Lu-JH04
NCT06636617
/ RecruitingEarly Phase 1IIT
Safety, Dosimetry and Treatment Response of 177Lu-JH04 in Patients with FAP-Positive Tumors
100 Clinical Results associated with 177Lu-JH04
Login to view more data
100 Translational Medicine associated with 177Lu-JH04
Login to view more data
100 Patents (Medical) associated with 177Lu-JH04
Login to view more data
100 Deals associated with 177Lu-JH04
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Adenomatous Polyposis ColiPhase 1
China
First Affiliated Hospital Of Fujian Medical University
21 Aug 2024
Advanced cancerPhase 1
China
First Affiliated Hospital Of Fujian Medical University
21 Aug 2024
Neoplasm MetastasisPhase 1
China
First Affiliated Hospital Of Fujian Medical University
21 Aug 2024
NeoplasmsPreclinical
China
Bivision Biomedical Technology (Nanjing) Co., Ltd.Bivision Biomedical Technology (Nanjing) Co., Ltd.
29 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free